IONS vs SNX · rev $514.0M vs P/E 16, rev $19.57B
Ionis Pharmaceuticals Inc (IONS) versus Synnex Corporation (SNX) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Synnex Corporation (SNX) is a electronics & computer distribution company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported SNX revenue for 2026-05-31 was $19.57B. Net income was $334.1M. Revenue was up 14.1% from 2026-02-28 to 2026-05-31. SNX currently screens at market cap $11.13B and trailing P/E 15.9.
IONS currently screens at market cap $12.28B. SNX currently screens at market cap $11.13B and trailing P/E 15.9.
Not investment advice. Open the IONS and SNX stock pages for the full models.
Not investment advice.